ArticleScientific reports2025
Piperine-loaded mesoporous silica nanoparticles as a promising strategy for targeting Echinococcus granulosus protoscoleces.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Smart Mesoporous Silica Nanoparticle-Based Drug Delivery Systems: Recent Advances in Biomedical Applications, Wound Healing and Therapeutic Perspectives.Pharmaceutics · 2026Review
- Piperine: From Green Extraction to Clinical Translation-A Review.Drug design, development and therapy · 2026Review
- Linalool as a potential agent against Toxoplasma gondii: an in vitro study.BMC research notes · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medical and surgical treatments for cystic echinococcosis (CE) are challenged by various complications. This study evaluates in vitro protoscolicidal activity of piperine-loaded mesoporous silica nanoparticles (PIP-MSNs) against protoscoleces of Echinococcus granulosus. MSNs were prepared by adding tetraethyl orthosilicate to cetyltrimethylammonium bromide and NaOH, and then loaded with PIP. The mean particle size and hydrodynamic diameter of MSNs were determined at 68 ± 4.5 and 101.4 ± 50.4 nm using transmission electron microscopy and dynamic light scattering, respectively. X-ray diffraction, Fourier-transform infrared analysis, and UV-spectrophotometry confirmed drug loading. Drug loading efficiency and drug loading capacity were calculated at 60% and 18%, respectively. The drug release profile confirmed a 75% PIP release plateau after about 24 h. The cytotoxicity assay showed cell viability > 90% in all concentrations used (≤ 512 µg/mL). E. granulosus protoscoleces were exposed to PIP-MSNs and their viability was assessed using the eosin exclusion test. In a dose-dependent manner (p < 0.001), exposure to 375 and 500 µg/mL of PIP-MSNs for 180 min killed 89.67 and 94.67% of protoscoleces, respectively. This study introduces PIP-MSNs as a potential protoscolicidal agent in the treatment of CE. Further studies are necessary to uncover safety aspects, biodistribution patterns, and potential combination therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.